HOME - Clinical cases - Implantology
 
 
24 February 2023

The inflammatory profile in patients with cardiovascular disease affected by peri-implantitis

Lara Figini


Cardiovascular disease (CVD), the leading cause of mortality worldwide, is an umbrella term to describe a range of clinical heart and circulatory diseases.

Total cardiovascular disease, coined by the American Heart Association and encompassing coronary heart disease, heart failure, stroke and hypertension, has a prevalence of around 48% in adults.

There are several literature studies supporting the independent association between chronic oral infection and different chronic noncommunicable diseases, including CVD.

Materials and methods

In a study published in June 2022 in the Journal of Periodontology, the authors investigated pro-inflammatory cytokine profiles in patients with or without cardiovascular disease (CVD) and with or without peri-implantitis.

Serum, peri-implant crevicular fluid (PICF), and gingival crevicular fluid (GCF) were collected from patients with (n = 82) or without (n = 46) CVD at the site of the most severe peri-implantitis, including sites with periodontitis.

Proinflammatory molecules including high sensitivity C-reactive protein (hsCRP), fibrinogen, interleukin-1 beta (IL-1β), IL-6, plasma tumor necrosis factor-alpha (TNF-α), matrix metalloproteinase 8 (MMP-8), osteoprotegerin (OPG), vascular endothelial growth factor (VEGF), IL-17, IL-8, tissue inhibitor of metalloproteinase-2 (TIMP-2), myeloperoxidase (MPO) and prostaglandin E2 (PGE2 ) were analyzed.

Researchers used the Kruskal-Wallis test to compare the groups. The diagnostic ability of each biomarker was evaluated using the chi-squared test and ROC analysis.

Results

Serum IL-1β, TNF-α, and fibrinogen were significantly higher in patients with CVD than in those without. Serum fibrinogen showed a trend for higher concentration in patients with radiographic bone loss (RBL) ≥2 mm (P = 0.08).

TNF-α in the peri-implant crevicular fluid PICF showed a significantly higher level of detection in CVD patients and this coincides with local peri-implant inflammation. Furthermore, MMP8 in the PICF was significantly higher in sites with radiographic RBL bone loss ≥2 mm than in areas with healthy implants, while IL-1β, IL-8, MMP-8 and TIMP-2 were significant predictors for peri-implant disease.

TNF-α collected in gingival crevicular fluid from patients with periodontitis was significantly associated with CVD cases.

Conclusions

From the data of this study, it can be concluded that the increased expression of local and systemic proinflammatory cytokines found in the present study supports the possible association between chronic peri-implantitis with increasing severity and CVD. However, conclusive evidence is weak.

For more information: "Pro-inflammatory profiles in cardiovascular disease patients with peri-implantitis."

Related articles

The number of people receiving dental implants is increasing annually as more individuals become aware of the advantages of replacing missing teeth.


This week, from March 7th to 9th, the 2024 Annual Meeting of the Academy of Osseointegration (AO) will commence at the Convention Center in Charlotte, North Carolina.


Despite this topic having been debated for years, the evidence for smoking as a risk factor for peri-implantitis still remains inconclusive.


Peri-implantitis is associated with bacterial plaque biofilms and with patients who have a history of periodontitis. Smoking is a risk factor for periodontitis, but the relationship between smoking...


This study examined what videos offer patients about peri-implantitis. Researchers also aimed to evaluate the quality of the information presented.


Read more

The purpose of this report is to describe a new technique to fabricate and deliver an implant-supported fixed prosthesis to the patient on the day of surgery, and to propose a protocol for the...


The Langkamp Allison Award recognizes a Pitt Dental Medicine third-year dental student interested in pursuing a career in dental education. 


VELMENI today unveiled VELMENI Voice, an AI-driven voice recognition tool designed to transform periodontal charting and clinical documentation. 


Angelalign Technology Inc. (6699.HK) (“Angel”) recently announced the expansion of its flexible iOrtho platform to include direct integration with the Dexis, Shining 3D, and Panda scanners. 


Following the first FDA clearance for technology that measures internal mobility in teeth, Perimetrics CEO and Chairman Robert Hayman is once again leading dentistry into a new era with InnerView, a...


 
 
 
 

 
 
 
 

Most popular

 
 

Events